Clinical utility and patient considerations in the use of ofatumumab in chronic lymphocytic leukemia
Anna Maria Frustaci, Alessandra Tedeschi, Paola Picardi, Roberto Cairoli, Marco MontilloDepartment of Hematology, Niguarda Cancer Center, Niguarda Ca' Granda Hospital, Milan, Italy Abstract: Treatment aim for chronic lymphocytic leukemia has been radically changed over the past years from p...
Guardado en:
Autores principales: | Frustaci AM, Tedeschi A, Picardi P, Cairoli R, Montillo M |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/338dbfaba9a843b1932eb2d55b9de2cb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Alemtuzumab in the treatment of fludarabine refractory B-cell chronic lymphocytic leukemia (CLL)
por: Marco Montillo, et al.
Publicado: (2008) -
Clinical role of obinutuzumab in the treatment of naive patients with chronic lymphocytic leukemia
por: Cerquozzi S, et al.
Publicado: (2015) -
Chronic lymphocytic leukemia in general practice
por: Đurović Ljiljana P.
Publicado: (2021) -
Chronic lymphocytic leukemia/small lymphocytic lymphoma
por: E. A. Nikitin, et al.
Publicado: (2020) - Lymphoma & Chronic Lymphocytic Leukemias